This Guideline addresses a number of medical issues which neurologists and other medical doctors who are involved in the medical management of patients with dementia are confronted with on a regular basis.
-
-
EAN NewsEAN NewsOther NewsMEPs & Stakeholders join forces to call for European leadership in health research – a BioMed Alliance initiative
The urgent need for coordination of research efforts and strong EU leadership in health research embedded in a European Council for Health Research have been identified as key policy topics during the BioMed Alliance Spring meeting. -
EAN NewsEAN NewsResearch
New EAN guideline on palliative care of people with severe, progressive multiple sclerosis
This EAN clinical practice guideline aims to provide practical help to clinicians caring for people with severe, progressive multiple sclerosis (MS). -
In May 2020, the EAN published for the first time guidelines for the management of medication overuse headache (MOH).
-
The European Academy of Neurology has launched a taskforce on Gender and Diversity in Neurology, with the overall mission to increase awareness and improve knowledge about sex, gender, ethnic and racial differences and disparities in neurological disorders with the aim to improve the outcome of care of neurological patients. -
The European Reference Networks for Rare Neurological Diseases (ERN-RND) and for Rare Neuromuscular Diseases (ERN EURO-NMD) organise joint webinars throughout the year in collaboration with EAN. -
The EANcore COVID-19 inatitive has launched a survey on neurological symptoms in COVID-19 patients. -
As the CoVID-19 pandemic spreads across Europe and the world, in response the European Academy of Neurology is launching EANcore CoVID-19. This resource aims to help neurologists in Europe and beyond prepare for and manage the challenges this global crisis is bringing. -
We are excited to announce that we have improved our online community platform, MyEAN! -
Rare Disease Day was launched in 2008 by EURORDIS, an alliance of patient organisations, and its Council of National Alliances, starting as a European event. It is now a major international event celebrated by rare disease organizations across the globe with… Continue Reading -
EAN signed a Memorandum of Understanding withISNA – International Society for Neuro-Immunology joining forces to promote optimal cooperation in Europe between both societies. -
EAN signed a Memorandum of Understanding with EPA – European Psychiatric Association joining forces to promote optimal cooperation in Europe between both societies. -
29 February 2020, a rare day, will be the thirteenth international Rare Disease Day. Many activities are organized in more than 100 countries to raise awareness amongst the general public and decision-makers about Rare Diseases and their impact on patients’… Continue Reading
-
We are happy to announce that there will be a total of 4 EAN-Days in 2020, and the first one will be in Almaty, Kazakhstan on 18 April. -
After more than five highly successful and productive years, EAN aims to continue the excellent work of its dedicated officers while giving an opportunity for new colleagues to contribute and bring fresh perspectives towards our mission to reduce the burden of neurological disease in Europe.